Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Morales

Showing results (171-180 of 186) with videos related to

Pageof 19
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infectionMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
Antibiotics (Basel, Switzerland)|December 16, 2020
Poly-ε-caprolactone Nanoparticles Loaded with 4-Nerolidylcatechol (4-NC) for Growth Inhibition of <i>Microsporum canis</i>Vanessa Raquel Greatti, Fernando Oda, Rodrigo Sorrechia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
ACS Nano|January 12, 2019
Exfoliated Graphene Leads to Exceptional Mechanical Properties of Polymer Composite FilmsYunsong Pang, Junlong Yang, Tyler E Curtis, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|February 6, 2019
A perspective on ecologically relevant plant-UV research and its practical applicationT Matthew Robson, Pedro J Aphalo, Agnieszka Katarzyna Banaś, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2020
Light-induced release of the cardioprotective peptide angiotensin-(1-9) from thermosensitive liposomes with gold nanoclustersJulian Bejarano, Aldo Rojas, Andrea Ramírez-Sagredo, et al.
Molecular and Cellular Neurosciences|July 20, 2024
iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell deathPanos Theofilas, Chao Wang, David Butler, et al.
Medicina Clinica|January 14, 2026
Initiation and titration of guideline-directed medical therapy during hospitalization for acute decompensation of heart failure with reduced ejection fractionSandra Valdivielso Moré, Núria Farré, Neus Badosa, et al.
Antiviral Therapy|July 30, 2019
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trialJose M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Human Vaccines & Immunotherapeutics|March 15, 2022
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adultsKevin L Russell, Richard E Rupp, Javier O Morales-Ramirez, et al.
Pageof 19

Showing results (171-180 of 186) with videos related to

Sort By:
Pageof 19
Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infectionMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
Antibiotics (Basel, Switzerland)|December 16, 2020
Poly-ε-caprolactone Nanoparticles Loaded with 4-Nerolidylcatechol (4-NC) for Growth Inhibition of <i>Microsporum canis</i>Vanessa Raquel Greatti, Fernando Oda, Rodrigo Sorrechia, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.
ACS Nano|January 12, 2019
Exfoliated Graphene Leads to Exceptional Mechanical Properties of Polymer Composite FilmsYunsong Pang, Junlong Yang, Tyler E Curtis, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|February 6, 2019
A perspective on ecologically relevant plant-UV research and its practical applicationT Matthew Robson, Pedro J Aphalo, Agnieszka Katarzyna Banaś, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 7, 2020
Light-induced release of the cardioprotective peptide angiotensin-(1-9) from thermosensitive liposomes with gold nanoclustersJulian Bejarano, Aldo Rojas, Andrea Ramírez-Sagredo, et al.
Molecular and Cellular Neurosciences|July 20, 2024
iPSC-induced neurons with the V337M MAPT mutation are selectively vulnerable to caspase-mediated cleavage of tau and apoptotic cell deathPanos Theofilas, Chao Wang, David Butler, et al.
Medicina Clinica|January 14, 2026
Initiation and titration of guideline-directed medical therapy during hospitalization for acute decompensation of heart failure with reduced ejection fractionSandra Valdivielso Moré, Núria Farré, Neus Badosa, et al.
Antiviral Therapy|July 30, 2019
Doravirine dose selection and 96-week safety and efficacy versus efavirenz in antiretroviral therapy-naive adults with HIV-1 infection in a Phase IIb trialJose M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Human Vaccines & Immunotherapeutics|March 15, 2022
A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adultsKevin L Russell, Richard E Rupp, Javier O Morales-Ramirez, et al.
Pageof 19